PetMed Express Inc. (NASDAQ:PETS) insider Bruce S. Rosenbloom sold 1,500 shares of PetMed Express stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $21.00, for a total value of $31,500.00. Following the sale, the insider now directly owns 41,767 shares in the company, valued at $877,107. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of PetMed Express Inc. (NASDAQ:PETS) opened at 20.63 on Monday. PetMed Express Inc. has a 12-month low of $15.61 and a 12-month high of $21.16. The firm’s 50-day moving average price is $20.43 and its 200-day moving average price is $19.32. The firm has a market capitalization of $416.31 million, a P/E ratio of 19.65 and a beta of 1.07.
PetMed Express (NASDAQ:PETS) last issued its earnings results on Monday, July 25th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.31 by $0.01. The company had revenue of $72.50 million for the quarter. PetMed Express had a net margin of 9.09% and a return on equity of 25.97%. The firm’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.29 earnings per share. Equities analysts predict that PetMed Express Inc. will post $1.11 earnings per share for the current fiscal year.
A number of equities research analysts have weighed in on the company. Zacks Investment Research raised PetMed Express from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a report on Wednesday, July 27th. Credit Suisse Group AG reaffirmed a “sell” rating and set a $13.00 price objective on shares of PetMed Express in a report on Tuesday, August 16th.
Large investors have recently modified their holdings of the stock. BlackRock Fund Advisors boosted its stake in shares of PetMed Express by 2.1% in the second quarter. BlackRock Fund Advisors now owns 1,328,794 shares of the company’s stock worth $24,928,000 after buying an additional 27,212 shares during the last quarter. Uniplan Investment Counsel Inc. boosted its stake in shares of PetMed Express by 5.3% in the second quarter. Uniplan Investment Counsel Inc. now owns 412,043 shares of the company’s stock worth $7,730,000 after buying an additional 20,689 shares during the last quarter. Royce & Associates LP boosted its stake in shares of PetMed Express by 33.2% in the first quarter. Royce & Associates LP now owns 401,500 shares of the company’s stock worth $7,191,000 after buying an additional 100,000 shares during the last quarter. Analytic Investors LLC boosted its stake in shares of PetMed Express by 9.5% in the second quarter. Analytic Investors LLC now owns 221,891 shares of the company’s stock worth $4,163,000 after buying an additional 19,188 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its stake in shares of PetMed Express by 2.9% in the second quarter. Principal Financial Group Inc. now owns 143,304 shares of the company’s stock worth $2,688,000 after buying an additional 4,066 shares during the last quarter. 75.76% of the stock is currently owned by institutional investors.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.